These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10890474)

  • 21. Quantitative determination of hirudin in blood and body fluids.
    Nowak G; Bucha E
    Semin Thromb Hemost; 1996; 22(2):197-202. PubMed ID: 8807717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation for patients with heparin-induced thrombocytopenia using recombinant hirudin during cardiopulmonary bypass.
    Liu H; Fleming NW; Moore PG
    J Clin Anesth; 2002 Sep; 14(6):452-5. PubMed ID: 12393116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series.
    Nuttall GA; Oliver WC; Santrach PJ; McBane RD; Erpelding DB; Marver CL; Zehr KJ
    Anesth Analg; 2003 Feb; 96(2):344-50, table of contents. PubMed ID: 12538175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of thrombin during reperfusion improves immediate postischemic myocardial function and modulates apoptosis in a porcine model of cardiopulmonary bypass.
    Jormalainen M; Vento AE; Lukkarinen H; Kääpä P; Kytö V; Lauronen J; Paavonen T; Suojaranta-Ylinen R; Petäjä J
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):224-31. PubMed ID: 17418736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [R-hirudin (lepirudin, refludan) as an alternative anticoagulant in heparin-induced thrombocytopenia during cardiopulmonary bypass connection].
    Shah AC; Genoni M; Niederhäuser U; Maloigne M; Turina M
    Schweiz Med Wochenschr; 2000 Jun; 130(23):896-9. PubMed ID: 10897491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.
    Riess FC; Poetzsch B; Madlener K; Cramer E; Doll KN; Doll S; Lorke DE; Kormann J; Mueller-Berghaus G
    Thorac Cardiovasc Surg; 2007 Jun; 55(4):233-8. PubMed ID: 17546553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hirudin determination in plasma can be strongly influenced by the prothrombin level.
    Lindhoff-Last E; Piechottka GP; Rabe F; Bauersachs R
    Thromb Res; 2000 Oct; 100(1):55-60. PubMed ID: 11053617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful use of hirudin during cardiac surgery using minimized extracorporeal circulation in patients with heparin-induced thrombocytopenia.
    Haneya A; Philipp A; Lehle K; Diez C; Rupprecht L; Kobuch R; Hirt SW; Zausig YA; Schmid C; Puehler T
    Ann Thorac Surg; 2011 Aug; 92(2):724-6. PubMed ID: 21801930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Off-pump coronary artery bypass grafting in a heparin-induced thrombocytopenia type II patient using hirudin.
    Carr CS; Rayner A; Ponte J; Desai JB
    Ann Thorac Surg; 2005 Feb; 79(2):696-8. PubMed ID: 15680867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-exposure to recombinant (r)-hirudin in antihirudin antibody-positive patients with a history of heparin-induced thrombocytopenia.
    Harenberg J; Huhle G; Wang LC; Hoffmann U; Song XH
    Br J Haematol; 2000 May; 109(2):360-3. PubMed ID: 10848825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant hirudin for extended aortic surgery in patients with heparin-induced thrombocytopenia.
    Bauer M; Koster A; Pasic M; Weng Y; Kuppe H; Hetzer R
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):191-2. PubMed ID: 10384203
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anticoagulant therapy and cardiopulmonary bypass].
    Lespron Robles Mdel C; Molina Méndez J
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-185-93. PubMed ID: 18938724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular drug highlight: hirudin.
    Cheng-Lai A
    Heart Dis; 1999; 1(1):41-9. PubMed ID: 11720603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi.
    Hellstern P; Bach J; Simon M; Saggau W
    J Extra Corpor Technol; 2007 Jun; 39(2):81-6. PubMed ID: 17672188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
    Pouplard C; May MA; Regina S; Marchand M; Fusciardi J; Gruel Y
    Br J Haematol; 2005 Mar; 128(6):837-41. PubMed ID: 15755289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hirudin-based anticoagulant strategy during isolated limb perfusion in a patient with heparin-induced thrombocytopenia.
    Lindemann W; Richter S; Schilling MK
    Melanoma Res; 2005 Aug; 15(4):287-90. PubMed ID: 16034307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.